These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 36573835
1. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder. Sirls LT, Schonhoff A, Waldvogel A, Peters KM. Neurourol Urodyn; 2023 Feb; 42(2):427-435. PubMed ID: 36573835 [Abstract] [Full Text] [Related]
2. A single-blind, randomized controlled trial to evaluate the effectiveness of transcutaneous tibial nerve stimulation (TTNS) in Overactive Bladder symptoms in women responders to percutaneous tibial nerve stimulation (PTNS). Martin-Garcia M, Crampton J. Physiotherapy; 2019 Dec; 105(4):469-475. PubMed ID: 30862384 [Abstract] [Full Text] [Related]
3. Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices. Lee UJ, MacDiarmid S, Matthews CA, Gillespie E, Peters KM. Adv Ther; 2024 Jul; 41(7):2635-2654. PubMed ID: 38748331 [Abstract] [Full Text] [Related]
4. Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator. Kapur A, Aalami Harandi A, Hartman-Kenzler J, Kim J. Neurourol Urodyn; 2024 Apr; 43(4):959-966. PubMed ID: 38390786 [Abstract] [Full Text] [Related]
6. A prospective study to assess the effectiveness and safety of the BlueWind System in the treatment of patients diagnosed with urgency urinary incontinence. Heesakkers JPFA, Toozs-Hobson P, Sutherland SE, Digesu A, Amundsen CL, McCrery RJ, De Wachter S, Kean ER, Martens F, Benson K, Ferrante KL, Cline KJ, Padron OF, Giusto L, Lane FL, Dmochowski RR. Neurourol Urodyn; 2024 Sep; 43(7):1491-1503. PubMed ID: 38634481 [Abstract] [Full Text] [Related]
7. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. J Urol; 2013 Jun; 189(6):2194-201. PubMed ID: 23219541 [Abstract] [Full Text] [Related]
8. Transcutaneous posterior tibial nerve stimulation in pediatric overactive bladder: A preliminary report. Patidar N, Mittal V, Kumar M, Sureka SK, Arora S, Ansari MS. J Pediatr Urol; 2015 Dec; 11(6):351.e1-6. PubMed ID: 26279104 [Abstract] [Full Text] [Related]
10. Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder. Tudor KI, Seth JH, Liechti MD, Ochulor J, Gonzales G, Haslam C, Fox Z, Pakzad M, Panicker JN. Clin Auton Res; 2020 Feb; 30(1):61-67. PubMed ID: 30074101 [Abstract] [Full Text] [Related]
11. Percutaneous tibial nerve stimulation versus sham efficacy in the treatment of refractory overactive bladder: outcomes following a shortened 6-week protocol, a prospective randomized controlled trial. Lashin AM, Eltabey NA, Wadie BS. Int Urol Nephrol; 2021 Dec; 53(12):2459-2467. PubMed ID: 34601705 [Abstract] [Full Text] [Related]
12. Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome. Ramírez-García I, Kauffmann S, Blanco-Ratto L, Carralero-Martínez A, Sánchez E. Neurourol Urodyn; 2021 Jan; 40(1):295-302. PubMed ID: 33118624 [Abstract] [Full Text] [Related]
13. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA. J Urol; 2017 Jul; 198(1):205-210. PubMed ID: 28189576 [Abstract] [Full Text] [Related]
14. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial. Preyer O, Umek W, Laml T, Bjelic-Radisic V, Gabriel B, Mittlboeck M, Hanzal E. Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262 [Abstract] [Full Text] [Related]
15. The effectiveness of different electrical nerve stimulation protocols for treating adults with non-neurogenic overactive bladder: a systematic review and meta-analysis. Zomkowski K, Kammers I, Back BBH, Moreira GM, Sonza A, Sacomori C, Sperandio FF. Int Urogynecol J; 2022 May; 33(5):1045-1058. PubMed ID: 35119495 [Abstract] [Full Text] [Related]
16. Factors influencing return for maintenance treatment with percutaneous tibial nerve stimulation for the management of the overactive bladder. Salatzki J, Liechti MD, Spanudakis E, Gonzales G, Baldwin J, Haslam C, Pakzad M, Panicker JN. BJU Int; 2019 May; 123(5A):E20-E28. PubMed ID: 30552801 [Abstract] [Full Text] [Related]
17. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study. Gilling P, Meffan P, Kaaki B, MacDiarmid S, Lucente V, Clark M, Sen SK, English S, Sand PK. Urology; 2021 Nov; 157():71-78. PubMed ID: 34048826 [Abstract] [Full Text] [Related]
18. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Sonmez R, Yildiz N, Alkan H. Ann Phys Rehabil Med; 2022 Jan; 65(1):101486. PubMed ID: 33429090 [Abstract] [Full Text] [Related]
19. Home-based transcutaneous tibial nerve stimulation for overactive bladder syndrome: a randomized, controlled study. Cava R, Orlin Y. Int Urol Nephrol; 2022 Aug; 54(8):1825-1835. PubMed ID: 35622269 [Abstract] [Full Text] [Related]
20. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO. Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]